Shulan Health
Chinese private hospital network operator running licensed hospitals across multiple provinces.
On the record
Checkpoint: Resolution of HKEX listing status after March 2024 refiling reportedly lapsed
The call
Shulan runs real hospitals with real licenses, but widening losses, a stalled IPO, and cashed up rivals buying hospital assets leave its ownership path unsettled.
Shulan Health runs actual hospitals across China, which requires government approval that competitors cannot easily get around. However, the company is losing huge amounts of money (RMB225 million in losses by early 2023), and its plan to raise money by selling stock in Hong Kong fell apart in 2024. Bigger, richer companies like Ping An Insurance and ByteDance are now buying up hospital networks instead, which means Shulan could get bought or squeezed out rather than grow on its own. The key question is whether the company can stop losing money and find a buyer willing to pay a fair price, or whether it becomes just another asset absorbed by a larger player.
Why
01
AI pressure: None apparent. AI diagnostic tools may eventually enter Chinese hospitals but nothing shown here threatens Shulan's bed and license based model. Could AI do the core job? Unlikely.
02
Bigger players: Ping An Insurance, Taikang Insurance, ByteDance. Well funded insurers and tech firms are buying up Chinese hospital assets while Shulan's own capital raising has stalled since 2021. Could a giant copy it? Probably.
03
What protects it. Owning licensed, operating hospitals across provinces gives real regulatory barriers that a cash rich buyer still has to work through or around.
What would change this call
Shulan Health refiles or is confirmed to have withdrawn its HKEX listing application. Shows whether the equity path to liquidity is reopening or definitively closed.
Ping An, Taikang, or ByteDance announces acquisition of a hospital group in Zhejiang or a Shulan peer market. Confirms incumbents are consolidating the space Shulan competes in.
Shulan Health publishes 2024 or 2025 audited financials showing revenue and loss trends. Reveals whether its multi-year losses are narrowing or deepening.
Ping An, Taikang, or ByteDance announces acquisition of a hospital group in Zhejiang or a Shulan peer market. Confirms incumbents are consolidating the space Shulan competes in.
Shulan Health publishes 2024 or 2025 audited financials showing revenue and loss trends. Reveals whether its multi-year losses are narrowing or deepening.
Key numbers
- Cumulative loss RMB225M through Q1 2023
- Revenue fell to RMB486M in Q1 2023 alone
- No major outside funding round since roughly 2021
Named risks
- HKEX IPO application reportedly lapsed September 2024 with no confirmed relisting.
- Cumulative net loss of RMB225 million through Q1 2023 with no financials disclosed since.
- Well-capitalized incumbents Ping An, Taikang, and ByteDance actively acquiring hospital assets in the same market.
- Three-year gap in public financial disclosure obscures current operating and cash position.
- Conflicting third-party reports on total funding raised ($85.69M vs $96.1M) signal data opacity.
Rivals, as read in July 2026
| Rival | Direction | Evidence |
|---|---|---|
| Ping An Insurance | gaining on | Acquired Peking University International Hospital, entering hospital ownership directly (reported 2024) |
| Taikang Insurance | gaining on | Acquired Suzhou Stomatological Hospital as part of insurer-led hospital consolidation (reported 2024) |
| ByteDance | gaining on | Acquired Meizhong Xuanhe women's and children's hospital in 2022 |
| Concord Healthcare Group | losing to | Listed on HKEX in January 2024 under code 2453.HK while Shulan's own listing stalled |
| Bayzed Health Group | contesting | Pursuing its own HKEX listing as of 2024, competing for the same IPO window as Shulan |
| Hygeia Healthcare | losing to | Described as sector leader trading around 27x P/E as of 2024, per industry reporting |
Questions people ask
- Is Shulan Health profitable in 2026?
- No confirmed profitability. Shulan Medical posted a net loss of RMB111 million in 2022 and RMB31.5 million in Q1 2023, for a cumulative loss of RMB225 million over about 2.5 years per its HKEX filing reported September 2023. No audited figures have surfaced since.
- Did Shulan Health complete its Hong Kong IPO?
- No. Shulan filed an HKEX application in August 2023 and resubmitted the prospectus on March 27, 2024, but per one aggregator source the application lapsed on September 27, 2024. No completed listing has been confirmed through mid-2026.
- Who owns Shulan Health?
- Zheng Jie, son of prominent Chinese academician Li Lanjuan, became chairman and legal representative after his mother resigned in 2020, according to a September 2023 report on the company's HKEX filing. Investors include Qiming Venture Partners and Hongshan Capital Group.
- Is Shulan Health's biggest competitive threat AI or rival hospital operators?
- Rival operators, not AI. Insurance and tech giants Ping An, Taikang, and ByteDance have been acquiring Chinese hospital assets directly, while peers like Concord Healthcare listed on HKEX in January 2024, ahead of Shulan's stalled listing.
- Could AI replace Shulan Health's hospitals?
- No. Shulan operates licensed inpatient and surgical hospitals, including a Zhejiang Provincial Level 3A hospital accredited in 2021, where physical care and licensed physicians cannot be automated; only its telehealth apps and documentation workflows face any AI-related exposure.
- What is Shulan Health's valuation?
- A $1.24 billion unicorn valuation has been cited by industry trackers, but this figure could not be corroborated against a dated primary source and should be treated as a vendor-claimed estimate rather than a confirmed valuation.
Timeline
- 2024-09-27HKEX IPO application reportedly lapsed or cancelled (aggregator-sourced, unverified independently)
- 2024-03-27Shulan Medical resubmitted its HKEX listing prospectus
- 2023-08Shulan Medical filed HKEX IPO application with CICC and CITIC Securities as sponsors
- 2021Shulan Hangzhou Hospital accredited as Zhejiang Provincial Level 3A Hospital
- 2020Li Lanjuan resigned as chairman; son Zheng Jie became chairman and legal representative
- 2018-03-31Hainan Boao Super Hospital opened
- 2016-12Series B funding round of $30.4 million completed
- 2013-11-26Company founding date most commonly cited (disputed across sources)
Revision history
29 July 2026
First assessed. Protection under test. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources
- What is Brief History of Shulan Health Company? (2025-07-11)
- Zheng Jie, the son of Li Lanjuan, has taken over Shulan Medical (2023-09-14)
- Bayzed joins IPO quest as medical rivalry heats up (2024-05-07)
- À qui appartient Shulan Health Company? (2025-07-11)
- Products, Competitors, Financials, Employees, Headquarters Locations
- 阿拉丁医护版 App (2025-12-14)
- Shulan Health 2026 Company Profile
- HKEX filing (Distinct Healthcare/卓正医疗)